AI alone won’t solve pharma’s fragmented safety data problem
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
AI alone won’t solve pharma’s fragmented safety data problem
Five genomics trends set to reshape research and care in 2026
Will pharma gets its data work back on track in 2026?
The New Year edition looks forward with vim, vigour and vision! We are, after all, in the midst of transformation. In drugs, through development, across trials and amid the melting both of digital and AI. It is – at once – exciting, curious and slightly imposing. In this edition we focus on all the aforementioned themes, and NHS turbulence, predictions for 2026, healthcare comms, the future of GLP-1s, online pharmacies, radiology progress, patient centricity 2.0 and more.
A night of marketing magic and communications flair!
Industry observers reflect on 2025’s tech-enabled progress
Is the tide finally turning on the UK access landscape?